FDA Asks Pfizer – BioNTech To Submit For COVID-19 Vaccine Emergency Use Nod For Youngest Children
Pfizer Inc (NYSE: PFE) and its partner BioNTech SE (NASDAQ: BNTX) have
Boston Scientific’s Q4 Earnings Slightly Above Consensus, FY22 Outlook Lag Estimates
Boston Scientific Corp (NYSE: BSX) generated
Novartis Expects FY22 Sales, Profit Growth; Sandoz Review Continues
Novartis AG (NYSE: NVS) reported a Q4 net income of $16.31 billion, up from $2.1 billion the previous year,
Gilead Q4 Earnings Highlights: Remdesivir Sales Fall 30%, Raises Dividend, FY22 EPS Below Estimates
Gilead Sciences Inc (NASDAQ: GILD) posted